THE FUTURE OF WORKING
WITH CUSTOMERS

Human-friendly | Omni-channel | AI-powered

Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software.

Close Button
Novartis - Tact.ai Customer and Investor
McKesson Ventures Logo
Lilly - Tact.ai Investor
Miscrosoft - Tact.ai Investor
Salesforce - Tact.ai Investor

INDUSTRY CHALLENGES AMPLIFIED IN THE POST PANDEMIC ERA

“The COVID-19 pandemic drove new imperatives to realize the power of data and technologies such as digital and virtual engagement that had been sitting at the peripheries for years.

Support for hybrid engagement strategy is a must in the post pandemic normal”

INTRODUCING
TACT CONTENT PLAYER FOR MS TEAMS

Tact Content Player for Microsoft Teams allows customer-facing teams to connect where customers prefer by supporting compliant video meetings on Microsoft Teams, sharing compliant content to enable better customer access and an improved user experience.

Content Player iPad Screen
Customer Friendly Email Mobile and iPad Screen
INTRODUCING
CUSTOMER FRIENDLY EMAIL

Customer Friendly Email (CFE) offers a reimagined compliant email experience created to help teams send more personalized communications, and appear in their customers’ inboxes more frequently with results as high as 1.5x industry open-rates.

TRANSFORM MULTIPLE SYSTEMS-OF-RECORD INTO A UNIFIED SYSTEM-OF-ENGAGEMENT

Tact logo connected with different systems like Microsoft, Salesforce. Calendar etc.

How Novartis is using AI to Improve Customer EngagemenT

Stan Tsvirko
Executive Director, Global Product Owner

FEATURED stories

The HCP Engagement Guide for Commercial Teams

A must read definitive guide to understanding evolution of HCP engagement post COVID-19

Trusted by life sciences &
Technology leaders

Novartis - Tact.ai Customer and Investor
McKesson Ventures Logo
Lilly - Tact.ai Investor
Miscrosoft - Tact.ai Investor
Salesforce - Tact.ai Investor

"As healthcare organizations prioritize interactions that improve patient outcomes, the opportunity to bring to market a next generation engagement platform for biopharma has emerged, Tact.ai  supports our thesis that commercial strategies for biopharma should account for both field force and prescriber needs, ensuring the right data is leveraged at the right time to enable the best decisions and support for patients."

Carrie Williams
Partner at McKesson Ventures

"Our Commercial and Medical teams at Novartis have been collaborating with Tact over the last two years to transform our field force and customer experience globally. Tact.ai aligns with our ambition to reimagine customer engagement for the New Normal."

Rana Lonnen
Managing Director at dRx Capital, the Novartis Data and Digital Health Venture Fund

Recognized by experts

Sales Performance Management

AI 100 Ranking - Sales and CRM

Life Science Commercial Operations

CRM Sales Technology

Top Sales Productivity Solutions

READY TO EXPERIENCE TACT?